Brandon Wummer
Overview
Explore the profile of Brandon Wummer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shalaby W, Reddy R, Wummer B, Huang P, Lee D, Razeghinejad R, et al.
Ophthalmol Glaucoma
. 2023 Dec;
7(3):251-259.
PMID: 38158079
Purpose: To compare the efficacy and safety of 2 nonvalved glaucoma drainage devices (GDDs): Ahmed ClearPath (ACP) vs. Baerveldt glaucoma implant (BGI). Design: Single-center, retrospective, comparative study. Participants: Consecutive patients...
2.
Lamm R, Cannaday S, Ponzini F, Moskal D, Lundgren M, Williamson J, et al.
HPB (Oxford)
. 2023 Apr;
25(7):807-812.
PMID: 37019725
Background: Postoperative opioid abuse following surgery is a major concern. This study sought to create an opioid reduction toolkit to reduce the number of narcotics prescribed and consumed while increasing...
3.
DiVita Dean B, Wildes T, Dean J, Yegorov O, Yang C, Shin D, et al.
J Immunother Cancer
. 2023 Feb;
11(2).
PMID: 36750252
Background: Glioma-induced immune dysregulation of the hematopoietic system has been described in a limited number of studies. In this study, our group further demonstrates that gliomas interrupt the cellular differentiation...
4.
Wummer B, Woodworth D, Flores C
J Neurooncol
. 2021 Jan;
151(1):21-28.
PMID: 33398531
Purpose: CNS malignancies are currently the most common cause of disease related deaths in children. Although brainstem gliomas are invariably fatal cancers in children, clinical studies against this disease are...
5.
Wildes T, Dyson K, Francis C, Wummer B, Yang C, Yegorov O, et al.
Clin Cancer Res
. 2020 Aug;
26(21):5689-5700.
PMID: 32788225
Purpose: Immunotherapy has been demonstrably effective against multiple cancers, yet tumor escape is common. It remains unclear how brain tumors escape immunotherapy and how to overcome this immune escape. Experimental...
6.
Grippin A, Dyson K, Qdaisat S, McGuiness J, Wummer B, Mitchell D, et al.
J Neurooncol
. 2020 Aug;
151(1):29-39.
PMID: 32757093
Introduction: Brain tumors remain especially challenging to treat due to the presence of the blood-brain barrier. The unique biophysical properties of nanomaterials enable access to the tumor environment with minimally...
7.
Grippin A, Wummer B, Wildes T, Dyson K, Trivedi V, Yang C, et al.
ACS Nano
. 2019 Nov;
13(12):13884-13898.
PMID: 31730332
Cancer vaccines initiate antitumor responses in a subset of patients, but the lack of clinically meaningful biomarkers to predict treatment response limits their development. Here, we design multifunctional RNA-loaded magnetic...
8.
Sayour E, Grippin A, De Leon G, Stover B, Rahman M, Karachi A, et al.
Nano Lett
. 2018 Sep;
18(10):6195-6206.
PMID: 30259750
Translation of nanoparticles (NPs) into human clinical trials for patients with refractory cancers has lagged due to unknown biologic reactivities of novel NP designs. To overcome these limitations, simple well-characterized...